Join Daniel Soffer, MD, a leading internist and lipid specialist and the immediate past president of the National Lipid Association, as he shares groundbreaking advancements in lipid management from the recent NLA meeting. Discover the importance of measuring patient responses, the benefits of combination therapies, and the latest in drug development for tackling lipid disorders.
Neuroimmunology of Cardiovascular Disease
Source : https://pubmed.ncbi.nlm.nih.gov/38613621/
The brain contains neuroimmune niches comprised of glia in the parenchyma and immune cells at the brain's borders, and there is strong evidence that these neuroimmune niches are important in...
A functional relationship between the brain and immune system during health and in CVD. The interplay between the brain and immune cells is robust, there are still many knowledge gaps that remain to be addressed.
Cardiac CT: Competition, complimentary or confounder
Source : https://pubmed.ncbi.nlm.nih.gov/38433089/
Coronary CT angiography (CCTA) has been gradually adopted into clinical practice over the last two decades. CCTA has high diagnostic accuracy, prognostic value, and unique features such as assessment of...
CCTA is a relatively new imaging modality which has very good diagnostic accuracy and prognostic value. At first glance, it may appear that CCTA is a competitor of functional imaging, but CCTA has limitations. Knowledge of such limitations and appropriate use of both CCTA and functional testing in a complementary fashion will lead to better...
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease
Source : https://pubmed.ncbi.nlm.nih.gov/38743805/
Recommendations from the "2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease" have been updated with new evidence to guide clinicians. In addition, new recommendations...
The "2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease" provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation subsets (ie, asymptomatic, chronic...
Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study
Source : https://pubmed.ncbi.nlm.nih.gov/38823406/
British Heart Foundation, NHS-AI award, Innovate UK, National Institute for Health and Care Research, and the Oxford Biomedical Research Centre.
The FAI Score captures inflammatory risk beyond the current clinical risk stratification and CCTA interpretation, particularly among patients without obstructive CAD. The AI-Risk integrates this information in a prognostic algorithm, which could be used as an alternative to traditional risk factor-based risk calculators.
